enVVeno Medical regains Nasdaq minimum bid price compliance; reports $28M cash at year-end

enVVeno Medical Corp

Received formal Nasdaq notice confirming compliance with minimum bid price rule; closing bid ≥ $1.00 for 10 consecutive business days Jan 20 - Feb 2, 2026, matter closed.
Cash and investments balance approximately $28 million as of December 31, 2025.
Company expects to share additional details on 2026 strategic plans in coming weeks; believes it is well-positioned for 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.